G
AIT ASSESSMENT IS an important component of the rehabilitation process. Instrumented gait assessment methods provide quantitative measures of gait kinematics, kinetics, and electromyographic activity of muscles. There is no doubt as to the superior advantage of instrumented gait assessment methods with respect to their quantitative nature and the possible degree of accuracy. However, despite the advantages, the literature contains multiple research studies that have used observational gait analysis methods, and in the clinical setting, observational gait analysis is routinely used. There are a number of reasons why instrumented gait analysis is not used in every research study nor routinely used in clinical practice. It is expensive, time intensive, and requires skilled analysis and interpretation, [1] [2] [3] [4] which can limit its practicality. The advantage of observational gait analysis, in general, has been that it is inexpensive and requires little or no technology. At the same time, the disadvantage of observational gait analysis versus instrumented gait analysis methods is that it has a lesser accuracy resolution. A criticism of observational gait analysis methods has been with regard to the relationship (or lack thereof) to the kinematic gait components they claim to measure. Studies [5] [6] [7] [8] [9] [10] [11] examining correlations between visual judgments and kinetic or kinematic measures are equivocal. Some have shown that because observational gait analysis depends on human visual judgment, it can be less reliable and less valid than instrumented gait measures, 1, 3 although others have reported high correlations between visual judgments and biomechanical measures. 6, [8] [9] [10] Despite this limitation, the fact is that observational gait analysis is widely used in clinical and research settings because of its ease of use and practicality.
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Since observational gait analysis is currently in use, it is important to use the optimal tool for the purpose at hand. A number of observational gait measures exist including the Wisconsin Gait Scale, 12, 13 Modified Gait Abnormality Rating Scale, 9 Rivermead Visual Gait Index, 14 Rancho Observational Gait Analysis, 15 Bath Assessment of Walking Inventory, 16 Tinetti Gait Scale (TGS), 17 and Gait Assessment and Intervention Tool (G.A.I.T.). 10 Both the Gait Abnormality Rating Scale and the G.A.I.T. have shown good (rϭ.75 and rϭ.76, respectively) correlation with selected kinematic measures.
9,10 Each of these observational measures has advantages and limitations, and each is capable of identifying a number of gait deviations; however, some may be more sensitive than others in assessing response to interventions for alleviating gait deviations.
For assessing response to interventions, a credible tool is one that correctly identifies clinically relevant deviations from normal gait and quantifies relevant changes in gait as a result of an intervention. 3 Without reliable measurement performance, we forfeit 2 kinds of important capabilities: (1) the ability to credit efficacious rehabilitation methods, and (2) the ability to justify the financial support for providing effective gait training interventions. The StrokeEdge Taskforce of the American Physical Therapy Association (APTA) Neurology Section recently recommended the TGS for use in research gait assessment, 18 as the preferred gait assessment tool. The G.A.I.T. is a more recently developed tool for gait assessment. 10 It is more detailed, containing more items than the TGS, in order to assess specific coordinated gait movements (31 vs 8 items). The G.A.I.T. is more homogeneous than the TGS, in that it contains items that assess coordinated gait components; that is, given items contain both the spatial and temporal aspects of coordination 19 (eg, amount of knee flexion [spatial] at midswing [temporal]), and it captures the amount of deviation from normal gait coordination. In contrast, the TGS includes given items that assess only the temporal aspect of gait description (eg, step length) or compensatory strategies such as gait asymmetry or step discontinuity. The brevity and heterogeneity of the TGS may limit its ability to detect some changes in gait in response to gait training. Despite this potential limitation, the TGS is widely used in the literature 20 and has been recommended by the APTA as the scale to use in research gait assessment. 18 Therefore, the purpose of the current work was to use secondary analysis to assess the performance of 2 observational gait measures, the TGS and the G.A.I.T., to identify changes in gait in response to gait training.
METHODS
Participants
A cohort of 44 subjects were evaluated, who were enrolled in a gait-training trial described elsewhere. 21 Inclusion criteria were as follows: greater than 6 months after a single stroke; inability to flex the hip, knee, and ankle normally in the sagittal plane, or hyperflexion or hyperextension of the knee during stance; and passive joint range of motion of the hip, knee, and ankle equal to the normal excursion needed for walking. Exclusion criteria included an inability to follow 2-level commands, peripheral neuropathy, and debilitating illness (eg, cancer). The study was approved by the medical center institutional review board, and a written informed consent process was conducted.
Intervention
All subjects received 48 sessions of gait training using a multimodal protocol as part of a clinical trial comparing intramuscular functional electrical stimulation (FES-IM) and no FES (46% received FES). 21 Treatment consisted of 1.5 hours per session, 4 sessions per week for 12 weeks, and included these 3 treatment aspects: (1) coordination exercise, (2) body weight-supported treadmill training (BWSTT), and (3) overground gait training (OG), with 46% of subjects receiving FES-IM. Exercise included practice of the coordinated joint movements that underlie gait components. 22 BWSTT was conducted using the Biodex500, a beginning with 30% body weight support and decreasing to 0%, according to the subject's ability to maintain normal, neutral alignment of the torso and stance limb. Walking training speed was increased up to .894m/s, as tolerated. OG included training in the following: torso, pelvic, hip, knee, and ankle position control during loading and weight bearing; swing hip, knee, and ankle flexion; and terminal swing knee extension/ankle dorsiflexion. Home exercises were coordination exercises performed for 1h/d. FES-IM was used to treat pelvic stability during stance phase, knee extension at loading, ankle dorsiflexion during swing, knee flexion at toeoff, and knee flexion during swing.
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Measures
The G.A.I.T. contains 31 items of coordinated gait components, divided into 3 sections: Section A contains 4 items for upper extremity and trunk movement control that occur during both stance and swing phase; Section B contains 14 items for the trunk and lower extremity that are unique to stance phase; and Section C contains 13 items for the trunk and lower extremity that are unique to swing phase. 10 Deviations from normal are listed as scoring choices within each item. Scoring for each item ranges from 0 (normal) up to 3, with deviations from normal defined and scored as 1, 2, or 3 points. The G.A.I.T. ranges from 0 (normal) to 62 points (greatest extent of gait deviations 10 The G.A.I.T. was developed by 8 experienced physical therapist clinicians 10 as a detailed observational measure of coordinated gait components to quantify response to gait training interventions. 10 With a scoring time of 20 minutes, the G.A.I.T. has been tested and can be used in a relatively low tech environment with a video camera to record the gait pattern and a video player with "playback," "stop-frame" capability for scoring some items.
The TGS contains 8 items assessing the following: deficits in coordinated gait components (2 items), compensatory strategies (5 items), and temporal aspects of gait (1 item). 17 Six items are scored as 0 (deviation) or 1 (normal) point; 2 items are scored as 0, 1, (deviations), or 2 (normal) points. The TGS ranges from 0 (most deviations) to 12 points (normal). The TGS has good interrater reliability (rϭ.80 -.89), moderate to good test-retest reliability (rϭ.72-.77), 27 and good intrarater reliability (rϭ.95). 28 The TGS was originally developed to identify abnormal gait 17 and takes 5 minutes to score. We chose to compare the G.A.I.T. with the TGS because the TGS is used widely in research studies 20 and has been recommended by the APTA as the observational measure of choice for research gait assessment.
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Testing
Twelve subjects ambulated without an assistive device on entering the study; 31 subjects ambulated with an assistive device (table 1). Each given subject was consistently tested at pre-/mid-/posttreatment tests (and without FES-IM), using their own consistent assistive device at each test session. The examiners in this study were physical therapists with more than 10 years of experience in clinical practice and gait assessment, and more than 3 years of experience in using the G.A.I.T. and TGS measures. For a given subject, the examiner was consistent for pre-/mid-/posttreatment measures, and the same examiner scored both the G.A.I.T. and the TGS measures. The examiners were blinded as to the purpose of the study.
Data Analysis
Overall change scores (pretreatment minus posttreatment; pretreatment minus midtreatment; midtreatment minus posttreatment) were calculated for the G.A.I.T. and the TGS. A change score was also calculated for each item for each measure. We generated descriptive statistics to examine the distribution of total and item change scores for each measure. The Wilcoxon signed-rank test was used for the following comparisons: pre-/post-, pre-/mid-, and mid-/posttreatment scores. The Sidak step-down procedure was used to correct for multiple comparisons. Correlation between gait coordination and gait speed was calculated using measured gait speed (m/s) and the G.A.I.T., using the Spearman model; this was repeated for the TGS and measured gait speed.
RESULTS
Total Score Analysis
The G.A.I.T. detected a significant pre-/posttreatment gain (Pϭ.0001; pre-/posttreatment median and interquartile range were 33.75 [9. 75] and 25.5 [8.625] , respectively); G.A.I.T. gain scores ranged from Ϫ1 (worsening) to ϩ17 (improvement) points. The TGS also detected a significant pre-/posttreatment gain (Pϭ.0001; pre-/posttreatment median and interquartile range were 6.0 [3.0] and 8.0 [3.0], respectively); TGS gain scores ranged from Ϫ3 (worsening) to ϩ6 (improvement) points. Descriptive statistics for the individual subject change scores for each measure revealed that 40 (91%) of the 44 subjects showed improved scores according to the G.A.I.T., 2 (4%) showed no change, and 2 (4%) showed a worsened score. According to the TGS, 26 (59%) of the 44 subjects showed improved scores, 16 (36%) showed no change, and 1 (2%) showed a worsened score (fig 1) . Figure 1 shows that there was a difference for the TGS versus the G.A.I.T. regarding the number of subjects who had no recovery of gait component performance. The G.A.I.T. measure identified that only 11.4% of subjects had none to minimal gains (0 -1 point), whereas the TGS suggested that 56.8% of subjects had none to minimal gains.
We conducted a secondary exploratory descriptive analysis to equilibrate the difference in the 2 scales, specifically the G.A.I.T., which has a total score of 62 points, and the TGS, which has a total score of 12 points (5:1 ratio). We can note that a 1-point gain on the TGS could be considered equivalent to a 5-point gain on the G.A.I.T. Using this algorithm, we found that 28 (63.6%) of the 44 subjects demonstrated greater than a 5-point pre-/posttreatment G.A.I.T. gain, which was greater than the 17 (38.6%) subjects demonstrating greater than a 1-point pre-/posttreatment TGS gain.
The G.A.I.T. detected a significant pre-/midtreatment gain (Pϭ.001; pre-/midtreatment median and interquartile range were 33.75 [9. 75] and 28.5 [9.0], respectively) and a significant mid-/posttreatment gain (Pϭ.0001; mid-/posttreatment median and interquartile range, 28.5 [9.0] and 25.5 [8.625] , respectively). The TGS also detected a significant pre-/midtreatment gain (Pϭ.0001; pre-/midtreatment median and interquartile For gait speed, there was a statistically significant pre-/ midtreatment gain (Pϭ.0001; pre-/midtreatment mean Ϯ SD, .396Ϯ.245m/s and .477Ϯ.284m/s, respectively). But the gain in gait speed from pre-/midtreatment was .08m/s, which is below the current standard of .16m/s for a minimally clinically significant change. 29 There was a significant mid-/posttreatment gain (Pϭ.001); mid-/posttreatment mean Ϯ SD values were .477Ϯ.284m/s and .536Ϯ.329m/s, respectively. However, the gain in gait speed from mid-/posttreatment was .06m/s, which is below the current standard of .16m/s for a minimally clinically significant change. 29 The overall pre-/ posttreatment gait speed gain was statistically significant (Pϭ.0001), with mean Ϯ SD values of .396Ϯ.245m/s and .536Ϯ.329m/s, respectively. However, the gain in gait speed from pre-/posttreatment was .14m/s, which is slightly below the current standard of .16m/s for a minimally clinically significant change.
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Individual Item Scores
The item content for both measures is listed in table 2, drawing potential commonalities for the G.A.I.T. and the TGS items. Although not a one-to-one commonality, the TGS item "step length and height" may be affected by the extent of movement excursion for swing phase hip flexion and/or knee flexion and/or ankle dorsiflexion; these latter 3 components are measured as separate items in the G.A.I.T., but the effects of these 3 items are considered as only a single item in the TGS. The G.A.I.T. measures trunk posture during both swing and stance phases, and within 2 different planes (sagittal and coronal), resulting in 4 individual items; the TGS measures trunk sway as a single item. Table 3 lists the items that are unique to either of the measures.
Individual items of each measure were able to distinguish gains. Table 4 lists the items for each measure that captured a gain score of 1 point or more. Twenty-eight (90%) of the 31 Ankle inversion (swing phase) 31 Toe position (swing phase) G.A.I.T. items, and all 8 TGS items were able to capture gains in at least 1 subject.
Treatment Effect for Each FES-IM and No FES Group
We examined the capability of the G.A.I.T. and TGS to detect a significant treatment effect for those who did not receive FES-IM (No FES, nϭ24) and those who did receive FES-IM (nϭ20). Results of this analysis are in table 5. Both measures were able to detect significant change in pre-/posttreatment scores in both the FES-IM and No FES groups. In addition, both measures detected significant change in pre-/ midtreatment scores for both groups; however, only the G.A.I.T. detected significant continued change from mid-to posttreatment.
DISCUSSION
Results showed that both measures were able to detect significant pre-/posttreatment gains in response to gait retraining in a group of 44 subjects with stroke. Both measures were able to identify change in some individual subjects as shown in figure 1 . However, the G.A.I.T. identified improvement in a much larger percentage of the subjects compared with the TGS (91% vs 59%). In fact, only 2 subjects showed no change in their total G.A.I.T. score; in contrast, 16 subjects showed no change according to the TGS. Justification of treatment has become critical in terms of obtaining insurance coverage for rehabilitation; when there is no credible progress measured, treatment is not continued. Notably, figure 1 shows that ac- Subjects Exhibited Gain Scores on the G.A.I.T. cording to the TGS, treatment would be terminated for 56.8% (25) of the subjects (0-to 1-point change in response to treatment), whereas treatment would be terminated for only 11.4% (5) of the individuals according to the G.A.I.T. measure.
In that case, 20 individuals would be deprived of treatment that would have had a positive effect on their coordinated gait. These results indicate that the G.A.I.T. was more sensitive than the TGS in discriminating actual change in coordination of walking ability. We further examined the capability of the G.A.I.T. and TGS to detect change for each of 2 treatment groups (FES-IM and No FES). Table 5 shows that the TGS detected significant change only during the first 24 sessions, but not for the subsequent 24 sessions from mid-to posttreatment. In contrast, the G.A.I.T. detected significant change not only during the first 24 sessions, but also during the latter 24 sessions. This finding illustrates that if only the TGS were used to examine treatment efficacy, it would erroneously be concluded that subjects had plateaued by the end of the first 24 sessions and did not have any further recovery during the latter 24 sessions. If guidelines were based on that information, stroke survivors would be deprived of efficacious gait training. Moreover, the G.A.I.T. results not only indicate that recovery continued throughout the latter 24 sessions, but also point to the possibility that even additional gait training might be beneficial and lead to further recovery. According to the G.A.I.T. measure, since there was no plateau between mid-and posttreatment, justification for follow-up research questions is revealed as follows: (1) how much more gait training would be beneficial? and (2) how much more recovery could be achieved?
There are several reasons why the G.A.I.T. may be more sensitive than the TGS. First, the G.A.I.T. is more homogeneous than the TGS. Item content for the TGS includes not only coordinated gait components (step length/height), but also compensatory strategies such as abnormal step width, gait asymmetry, and step discontinuity (see table 3 ). Subjects may have improved on some coordinated gait components measured by the G.A.I.T., but perhaps not all the gait components encompassed by the more global compensatory strategies assessed by the TGS. For example, subjects improved weight shift and pelvic position as measured with the G.A.I.T., but still had some balance deficit that required the compensatory strategy of an abnormally wide step width measured by the TGS. Second, the G.A.I.T. is more detailed, containing more items and possessing a higher total score (31 items, 62 points) than the TGS (8 items, 12 points). Table 3 shows that the G.A.I.T. possesses a greater number of unique items versus the TGS. Hip, knee, and ankle excursion during the swing phase of gait each have the ability to affect step length and height. These individual joint excursions are measured and scored separately as individual items in the G.A.I.T., whereas the effects of these 3 items are considered together in only 1 global item (step length and height) in the TGS. In other words, step length and height are assessed by the TGS, but the specific coordinated means that were used to achieve normal step length and height are not measured. Without the identification of the specific gait dyscoordination, and recovery thereof, the clinician and the researcher are not provided with clear guidance for gait coordination training and with clear research evidence, respectively.
A second example of the advantage of a more detailed measure is that the G.A.I.T. has 14 items to assess trunk, pelvic, hip, knee, and ankle coordination gait components during the stance phase of gait, and 13 items for coordination gait components during the swing phase of gait. The TGS has 1 item assessing stance phase of gait (step width) and 2 items assessing swing phase: right step length/height and left step length/height. As shown in table 4, at least 10 subjects demonstrated improvement on 9 stance and 10 swing phase gait component movements according to the G.A.I.T. measure; however, the 1 relevant swing-phase coordination item in the TGS was not constructed in a manner that was sufficient to capture those gains. For example, the improved knee flexion in swing phase that was captured by the G.A.I.T. measure may not have been sufficient for detection by the TGS, which required recovery of whole-limb performance to detect change in the more gross-movement TGS item.
A third reason why the G.A.I.T. measure is more sensitive may be that the G.A.I.T. is capable of measuring incremental changes within given gait components. Twenty-four of the G.A.I.T. items require a determination of the degree of the deficit. The G.A.I.T. was designed in this way to capture an incremental response to treatment within the domain of the given gait component. For example, the item "knee-midswing" is rated as 0 (60°, normal), 1 (45°-55°), 2 (25°-45°), or 3 (0°-25°) depending on the amount of knee flexion performed. During treatment, a patient may improve gradually, over time, in the amount of knee flexion executed at midswing. The capability of a gait measure to show incremental change over time allows the clinician to document that the patient has not yet plateaued and deserves more treatment for the measured rehabilitation potential. Accurately identified gains illustrate for the researcher that a new protocol is efficacious and/or that full recovery may not have yet been reached and study is warranted of additional treatment duration. The incremental improved knee flexion would be reflected in a change score in the G.A.I.T. However, for the TGS, this incremental improvement in knee flexion cannot be captured, and it would appear that the patient had not responded to intervention. In that case, promising treatment would be denied to a patient who actually was exhibiting progress (but unmeasured) and potential for further recovery. In the realm of research, a potentially efficacious treatment might be inaccurately classified as not beneficial, if incremental gains are not identified.
Gait measures should not only determine whether a deficit exists, but also assist in clinical decision-making, guiding treatment decisions. The TGS was designed as a clinical measure to detect obvious problems with gait (ie, identify abnormal gait). 17 Its advantage is that it is simple to use, only takes a few minutes to administer, and does identify obvious problems with gait. However, because it is not comprehensive, it is not able to guide treatment decisions aimed at recovery of gait coordination and normal walking ability. A measure such as the G.A.I.T. that is comprehensive is able to guide treatment by assisting the therapist with identifying deficits in specific gait components. For example, the TGS will identify a deficit in the ability to bring the swing foot past the stance foot (abnormal gait characteristic). However, the G.A.I.T. provides the therapist with an assessment tool and a score regarding whether this inability is due to insufficient hip, knee, or ankle dorsiflexion during swing or insufficient hip or knee extension during stance, or abnormal weight shift during stance. Any of these deficits lead to the 1 deficit measured by the TGS single item (bringing the swing foot past the stance foot). The G.A.I.T. provides a means to analyze several sources of the gait deficits, providing a guide to focus on specific training options to improve gait performance.
Gait speed is widely recommended as an outcome measure in the poststroke gait literature, and some would argue that it is the criterion standard measurement for "gait function." [30] [31] [32] According to gait speed (m/s) results in the current study, there was a statistically significant gain for the paired comparisons between each of the data acquisition time points (pre-/mid-/ posttreatment). Some have reported that a gait speed gain of .16 m/s is a minimal clinically important difference that can be used by clinicians to develop goals and interpret progress in patients after stroke. 29 If that criterion were exclusively used in the current study, we would have to conclude that none of the comparisons (pre-/posttreatment; pre-/midtreatment; and mid-/ posttreatment) reached a gain in gait speed of .16m/s, and so were not clinically significant. Gait speed is related in a number of ways to gait coordination. Gait coordination can be considered a higher order property of the human system, controlled by the central nervous system. 19 The relationship between gait coordination and gait speed is complex. We do know that normally coordinated gait results in a self-selected gait speed averaging 1.39m/s, 33, 34 which is the optimal walking speed in terms of energy expenditure. 35 We also know that impaired gait coordination can lead to abnormally reduced gait speed as well as poor walking endurance after stroke. Some stroke survivors can adopt compensatory strategies such as hip hiking and circumducting that can be observed in a "stiff-legged" gait. These compensatory strategies may enable a faster walking speed, 36 but at the same time, they are less efficient in terms of energy cost versus normal gait coordination 37 and can be less desirable for a number of reasons 19 such as poor safety and propensity to fall. 25 The complex relationship between gait coordination and gait speed justifies the use of both types of measures in analyzing gait deficits and response to gait training.
Study Limitations
There are a number of available tools for characterizing and measuring gait coordination. It was beyond the scope of the current study to assess them all. This study was focused to study 2 observational gait measures. We selected the G.A.I.T. because it is a detailed and homogeneous measure of coordinated gait components that informs the therapist of gait deviations and provides a mechanism to evaluate progress and establish treatment goals for gait training. We selected the TGS because it is widely used in the literature and was recommended by the APTA StrokeEdge Taskforce as the observational gait measure of choice for research. The study sample was limited to 44 stroke survivors who were 6 months poststroke. The gait-training protocol that produced the pre-/posttreatment scores was confined to the combination of exercise, BWSTT, and OG, with or without FES-IM, depending on assignment. The types of measures were limited to 2 observational gait coordination measures and gait speed.
CONCLUSIONS
In the current health care environment, it is critical to measure response to interventions in a manner that is accurate, comprehensive, and sensitive to incremental change. Without this capability, we forfeit the ability to credit efficacious rehabilitation interventions and to justify the financial support of providing effective gait-training methods. The current study demonstrated that the G.A.I.T. is more sensitive for individual stroke survivors than the TGS in identifying improvement in volitional control of gait component coordination in response to gait training. We found that the TGS missed the accurate identification of recovery of gait coordination in a large percentage of stroke survivors. The G.A.I.T. exhibited better capability than the TGS in identifying a significant response to treatment for a group of chronic stroke survivors.
